CDEX ValiMed medication safety system selected by Brigham and Women's Hospital

CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces that Brigham and Women's Hospital (Boston, MA) has selected the CDEX ValiMed™ Medication Safety System as part of its Medication Safety Program. Studies worldwide continue to show that mistakes in the compounding of high-risk medications occur and result in substantial harm to patients and economic loss to hospitals. In an 18-month University of Michigan Health System study, ValiMed identified 5 major medical errors (see> "We selected two ValiMed units to provide additional assurance of accuracy for our robotic compounding and to validate the return of narcotics," said William Churchill, Executive Director of Pharmacy. "Assuring the safety of our patients is job one at Brigham and ValiMed will help with that goal."

"Brigham and Women's Hospital joins the list of other world class hospitals that have selected ValiMed as part of their Medication Safety Program and we look forward to working with Bill and his staff to integrate ValiMed into their daily practices," said Greg Firmbach, CDEX Senior Vice President.